Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men

Abstract

Prior studies report slightly lower prostate-specific antigen (PSA) levels among obese men. To understand this effect, we investigated the association between PSA and blood HbA1c, C-peptide, leptin and adiponectin levels in African-American (AA) (n=121) and Caucasian (CA) (n=121) men. Among AA men, PSA levels decreased with increasing C-peptide levels (PSA=0.99, 0.93, 0.75 and 0.53 ng ml−1 across quartiles of C-peptide, respectively; Ptrend=0.005). Among CA men, PSA levels decreased with increasing HbA1c (PSA=0.84, 0.73, 0.77 and 0.45 ng ml−1 across quartiles of HbA1c, respectively; Ptrend=0.005). This may suggest that metabolic disturbances related to metabolic syndrome or diabetes affect the ability to detect early-stage prostate cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM . Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006; 295: 1549–1555.

    Article  CAS  PubMed  Google Scholar 

  2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106–130.

    Article  PubMed  Google Scholar 

  3. Ribeiro R, Lopes C, Medeiros R . The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives. Prostate Cancer Prostatic Dis 2006; 9: 19–24.

    Article  CAS  PubMed  Google Scholar 

  4. Andersson S-O, Wolk A, Bergstrom R, Adami H-O, Engholm G, Englund A et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 1997; 89: 385–389.

    Article  CAS  PubMed  Google Scholar 

  5. Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ . Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 2001; 10: 345–353.

    CAS  PubMed  Google Scholar 

  6. Snowdon D, Phillips R, Choi W . Diet, obesity and risk of fatal prostate cancer. Am J Epidemiol 1984; 120: 244–250.

    Article  CAS  PubMed  Google Scholar 

  7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625.

    Article  PubMed  Google Scholar 

  8. Freedland SJ, Aronson WJ, Kane CJ, Presti Jr JC, Amling CL, Elashoff D et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital Database Study Group. J Clin Oncol 2004; 22: 446–453.

    Article  PubMed  Google Scholar 

  9. Strom SS, Wang X, Pettaway CA, Logothetis CJ, Yamamura Y, Do KA et al. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin Cancer Res 2005; 11: 6889–6894.

    Article  CAS  PubMed  Google Scholar 

  10. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ et al. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology 2005; 66: 1060–1065.

    Article  PubMed  Google Scholar 

  11. Freedland S, Giovannucci E, Platz E . Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 2006; 17: 5–9.

    Article  PubMed  Google Scholar 

  12. MacInnis R, English D . Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006; 17: 989–1003.

    Article  PubMed  Google Scholar 

  13. Laukkanen JA, Laaksonen DE, Niskanen L, Pukkala E, Hakkarainen A, Salonen JT . Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev 2004; 13: 1646–1650.

    CAS  PubMed  Google Scholar 

  14. Lund Haheim L, Wisloff TF, Holme I, Nafstad P . Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 2006; 164: 769–774.

    Article  CAS  PubMed  Google Scholar 

  15. von Hafe P, Pina F, Perez A, Tavares M, Barros H . Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 2004; 12: 1930–1935.

    Article  PubMed  Google Scholar 

  16. Chang S, Hursting SD, Contois JH, Strom SS, Yamamura Y, Babaian RJ et al. Leptin and prostate cancer. Prostate 2001; 46: 62–67.

    Article  CAS  PubMed  Google Scholar 

  17. Stattin P, Soderberg S, Hallmans G, Bylund A, Kaaks R, Bergh A et al. Leptin is associated with increased prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab 2001; 86: 1341–1345.

    CAS  PubMed  Google Scholar 

  18. Saglam K, Aydur E, Yilmaz M, Goktas S . Leptin influences cellular differentiation and progression in prostate cancer. J Urol 2003; 169: 1308–1311.

    Article  CAS  PubMed  Google Scholar 

  19. Hsing AW, Gao YT, Chua Jr S, Deng J, Stanczyk FZ . Insulin resistance and prostate cancer risk. J Natl Cancer Inst 2003; 95: 67–71.

    Article  CAS  PubMed  Google Scholar 

  20. Hammarsten J, Hogstedt B . Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 2005; 41: 2887–2895.

    Article  CAS  PubMed  Google Scholar 

  21. Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 2007; 109: 675–684.

    Article  PubMed  Google Scholar 

  22. Tande AJ, Platz EA, Folsom AR . The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol 2006; 164: 1094–1102.

    Article  PubMed  Google Scholar 

  23. Porter MP, Stanford JL . Obesity and the risk of prostate cancer. Prostate 2005; 62: 316–321.

    Article  PubMed  Google Scholar 

  24. Bradbury BD, Wilk JB, Kaye JA . Obesity and the risk of prostate cancer (United States). Cancer Causes Control 2005; 16: 637–641.

    Article  PubMed  Google Scholar 

  25. Lagiou P, Signorello LB, Trichopoulos D, Tzonou A, Trichopoulou A, Mantzoros CS . Leptin in relation to prostate cancer and benign prostatic hyperplasia. Int J Cancer 1998; 76: 25–28.

    Article  CAS  PubMed  Google Scholar 

  26. Stattin P, Kaaks R, Johansson R, Gislefoss R, Soderberg S, Alfthan H et al. Plasma leptin is not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 474–475.

    CAS  PubMed  Google Scholar 

  27. Hsing AW, Chua S, Gao Y-T, Gentzschein E, Chang L, Deng J et al. Prostate cancer risk and serum levels of insulin and leptin: a population based-study. J Natl Cancer Inst 2001; 93: 783–791.

    Article  CAS  PubMed  Google Scholar 

  28. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2006; 15: 1977–1983.

    Article  PubMed  Google Scholar 

  29. Littman AJ, White E, Kristal AR . Anthropometrics and prostate cancer risk. Am J Epidemiol 2007; 165: 1271–1279.

    Article  PubMed  Google Scholar 

  30. Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV et al. Body mass index, weight change, and risk of prostate cancer in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 63–69.

    Article  PubMed  Google Scholar 

  31. Giovannucci E, Rimm E, Stampfer M, Colditz GA, Willett WC . Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 1998; 9: 3–9.

    Article  CAS  PubMed  Google Scholar 

  32. Rodriguez C, Patel AV, Mondul AM, Jacobs EJ, Thun MJ, Calle EE . Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol 2005; 161: 147–152.

    Article  PubMed  Google Scholar 

  33. Velicer CM, Dublin S, White E . Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications. Prostate Cancer Prostatic Dis 2006; 10: 46–51.

    Article  PubMed  Google Scholar 

  34. Kasper JS, Giovannucci E . A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2056–2062.

    Article  PubMed  Google Scholar 

  35. Fowke JH, Signorello LB, Chang SS, Matthews CE, Buchowski MS, Cookson MS et al. Effects of obesity and height on PSA and percent free PSA levels among African-American and Caucasian men. Cancer 2006; 107: 2361–2367.

    Article  CAS  PubMed  Google Scholar 

  36. Kristal AR, Chi C, Tangen C, Goodman PJ, Etzioni R, Thompson IM . Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer 2005; 106: 320–328.

    Article  Google Scholar 

  37. Baillargeon J, Pollock BH, Kristal AR, Bradshaw P, Hernandex J, Basler J et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 2005; 103: 10920–11095.

    Google Scholar 

  38. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Salonen R et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003; 149: 601–608.

    Article  CAS  PubMed  Google Scholar 

  39. Philips GB, Jing T, Heymsfield SB . Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism 2003; 52: 784–790.

    Article  Google Scholar 

  40. Svartberg J, von Muhlen D, Sundsfjord J, Jorde R . Waist circumference and testosterone levels in community dwelling men. The Tromso study. Eur J Epidemiol 2004; 19: 657–663.

    Article  CAS  PubMed  Google Scholar 

  41. Kaaks R, Lukanova A, Rinaldi S, Biessy C, Soderberg S, Olsson T et al. Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls. Eur J Cancer Prev 2003; 12: 309–315.

    Article  CAS  PubMed  Google Scholar 

  42. Gapstur SM, Gann PH, Kopp P, Colangelo L, Longcope C, Liu K . Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 2002; 11: 1041–1047.

    CAS  PubMed  Google Scholar 

  43. Freedland SJ, Sokoll Lj, Mangold La, Bruzek Dj, Mohr P, Yiu Sk et al. Serum leptin and pathological findings at the time of radical prostatectomy. J Urol 2005; 173: 773–776.

    Article  CAS  PubMed  Google Scholar 

  44. Freedland SJ, Sokoll LJ, Platz EA, Mangold LA, Bruzek DJ, Mohr P et al. Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy. J Urol 2005; 174: 1266–1270.

    Article  CAS  PubMed  Google Scholar 

  45. Signorello LB, Hargreaves MK, Steinwandel MD, Zheng W, Cai Q, Schlundt DG et al. Southern community cohort study: establishing a cohort to investigate health disparities. J Natl Med Assoc 2005; 97: 972–979.

    PubMed  PubMed Central  Google Scholar 

  46. Ding EL, Song Y, Malik VS, Liu S . Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006; 295: 1288–1299.

    Article  CAS  PubMed  Google Scholar 

  47. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL . Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 2002; 25: 55–60.

    Article  CAS  PubMed  Google Scholar 

  48. Muller M, Grobbee DE, den TI, Lamberts SW, van der Schouw YT . Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 2005; 90: 2618–2623.

    Article  CAS  PubMed  Google Scholar 

  49. Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM . Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endocrinol Metab 2002; 87: 4522–4527.

    Article  CAS  PubMed  Google Scholar 

  50. Hammarsten J, Hogstedt B, Holthuis N, Mellstrom D . Components of the metabolic syndrome—risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1998; 1: 157–162.

    Article  CAS  PubMed  Google Scholar 

  51. Dahle SE, Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Hsing AW . Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2002; 168: 599–604.

    Article  CAS  PubMed  Google Scholar 

  52. Parsons JK, Carter HB, Partin AW, Windham BG, Metter EJ, Ferrucci L et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 2006; 91: 2562–2568.

    Article  CAS  PubMed  Google Scholar 

  53. Fowke JH, Motley SS, Cookson MS, Concepcion R, Chang SS, Wills ML et al. The association between body size, prostate volume and prostate-specific antigen. Prostate Cancer Prostatic Dis 2006; 10: 137–142.

    Article  PubMed  Google Scholar 

  54. Saaddine JB, Fagot-Campagna A, Rolka D, Narayan KMV, Geiss L, Eberhardt M et al. Distribution of HbA1c levels for children and young adults in the US: Third National Health and Nutrition Examination Survey. Diabetes Care 2002; 25: 1326–1330.

    Article  PubMed  Google Scholar 

  55. Osei K, Schuster DP, Amoah AG, Owusu SK . Diabetes in Africa. Pathogenesis of type 1 and type 2 diabetes mellitus in sub-Saharan Africa: implications for transitional populations. J Cardiovasc Risk 2003; 10: 85–96.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by RO1CA92447.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J H Fowke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fowke, J., Matthews, C., Buchowski, M. et al. Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men. Prostate Cancer Prostatic Dis 11, 264–269 (2008). https://doi.org/10.1038/sj.pcan.4501022

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4501022

Keywords

This article is cited by

Search

Quick links